Standard BioTools Inc. Increase (Decrease) in Accounts Receivable
Standard BioTools Inc. (LAB) reported Increase (Decrease) in Accounts Receivable of $610.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-05
- Standard BioTools Inc. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was -$1.25M, a 552.17% decline year-over-year.
- Standard BioTools Inc. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was $1.86M, a 8.07% decline year-over-year.
- Standard BioTools Inc. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was -$6.73M.
- Standard BioTools Inc. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $5.79M, a 111.46% increase year-over-year.
- Standard BioTools Inc. increase (decrease) in accounts receivable for fiscal 2025 was $1.36M.
- Standard BioTools Inc. increase (decrease) in accounts receivable for fiscal 2024 was -$8.97M, a 399.80% decline from fiscal 2023.
- Standard BioTools Inc. increase (decrease) in accounts receivable for fiscal 2023 was $2.99M.
- Standard BioTools Inc. increase (decrease) in accounts receivable for fiscal 2022 was -$1.06M.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $610.00K 10-Q · filed 2026-08-05 | -$6.12M derived: sum of 3 quarters · filed 2026-08-05 | -$326.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $1.86M 10-Q · filed 2026-05-06 | -$4.87M derived: sum of 2 quarters · filed 2026-05-06 | $922.00K derived: sum of 3 quarters · filed 2026-05-06 | $1.20M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$6.73M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$936.00K derived: sum of 2 quarters · filed 2026-03-16 | -$660.00K derived: sum of 3 quarters · filed 2026-08-05 | $1.36M 10-K · filed 2026-03-16 |
| 2025-09-30 | $5.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $6.07M derived: sum of 2 quarters · filed 2026-08-05 | $8.09M 10-Q · filed 2025-11-04 | $1.40M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $276.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $2.30M 10-Q · filed 2026-08-05 | -$4.40M derived: sum of 3 quarters · filed 2026-08-05 | -$1.66M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $2.02M 10-Q · filed 2026-05-06 | -$4.67M derived: sum of 2 quarters · filed 2026-05-06 | -$1.93M derived: sum of 3 quarters · filed 2026-05-06 | -$6.26M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | -$6.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$3.96M derived: sum of 2 quarters · filed 2026-03-16 | -$8.28M derived: sum of 3 quarters · filed 2026-03-16 | -$8.97M 10-K · filed 2026-03-16 |
| 2024-09-30 | $2.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$1.59M derived: sum of 2 quarters · filed 2025-11-04 | -$2.27M 10-Q · filed 2025-11-04 | $1.40M derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-06-30 | -$4.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-15 | -$5.01M 10-Q · filed 2025-08-15 | -$1.34M derived: sum of 3 quarters · filed 2026-03-16 | $217.00K derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-03-31 | -$686.00K 10-Q · filed 2025-05-06 | $2.98M derived: sum of 2 quarters · filed 2026-03-16 | $4.54M derived: sum of 3 quarters · filed 2026-03-16 | $5.33M derived: sum of 4 quarters · filed 2026-03-16 |
| 2023-12-31 | $3.67M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $5.23M derived: sum of 2 quarters · filed 2026-03-16 | $6.02M derived: sum of 3 quarters · filed 2026-03-16 | $2.99M 10-K · filed 2026-03-16 |
| 2023-09-30 | $1.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $2.35M derived: sum of 2 quarters · filed 2024-11-06 | -$677.00K 10-Q · filed 2024-11-06 | -$617.00K derived: sum of 4 quarters · filed 2025-03-11 |
| 2023-06-30 | $789.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$2.24M 10-Q · filed 2024-08-06 | -$2.18M derived: sum of 3 quarters · filed 2025-03-11 | $3.98M derived: sum of 4 quarters · filed 2025-03-11 |
| 2023-03-31 | -$3.03M 10-Q · filed 2024-05-09 | -$2.97M derived: sum of 2 quarters · filed 2025-03-11 | $3.19M derived: sum of 3 quarters · filed 2025-03-11 | -$1.17M derived: sum of 4 quarters · filed 2025-03-11 |
| 2022-12-31 | $60.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $6.21M derived: sum of 2 quarters · filed 2025-03-11 | $1.85M derived: sum of 3 quarters · filed 2025-03-11 | -$1.06M 10-K · filed 2025-03-11 |
| 2022-09-30 | $6.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $1.79M derived: sum of 2 quarters · filed 2023-11-07 | -$1.12M 10-Q · filed 2023-11-07 | $3.59M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | -$4.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$7.28M 10-Q · filed 2023-08-08 | -$2.57M derived: sum of 3 quarters · filed 2023-08-08 | -$4.59M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | -$2.92M 10-Q · filed 2023-05-09 | $1.79M derived: sum of 2 quarters · filed 2023-05-09 | -$227.00K derived: sum of 3 quarters · filed 2023-05-09 | $197.00K derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $4.71M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $2.69M derived: sum of 2 quarters · filed 2023-03-14 | $3.11M derived: sum of 3 quarters · filed 2023-03-14 | -$6.73M 10-K · filed 2023-03-14 |
| 2021-09-30 | -$2.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$1.59M derived: sum of 2 quarters · filed 2022-11-09 | -$11.44M 10-Q · filed 2022-11-09 | -$2.84M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $424.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$9.42M 10-Q · filed 2022-08-09 | -$824.00K derived: sum of 3 quarters · filed 2022-08-09 | $7.26M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | -$9.84M 10-Q · filed 2022-05-09 | -$1.25M derived: sum of 2 quarters · filed 2022-05-09 | $6.84M derived: sum of 3 quarters · filed 2022-05-09 | $2.52M derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | $8.60M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $16.68M derived: sum of 2 quarters · filed 2022-03-08 | $12.36M derived: sum of 3 quarters · filed 2022-03-08 | $7.63M 10-K · filed 2022-03-08 |
| 2020-09-30 | $8.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $3.76M derived: sum of 2 quarters · filed 2021-11-09 | -$967.00K 10-Q · filed 2021-11-09 | $4.30M derived: sum of 4 quarters · filed 2022-03-08 |
| 2020-06-30 | -$4.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | -$9.05M 10-Q · filed 2021-08-06 | -$3.79M derived: sum of 3 quarters · filed 2022-03-08 | -$9.40M derived: sum of 4 quarters · filed 2022-03-08 |
| 2020-03-31 | -$4.73M 10-Q · filed 2021-05-07 | $540.00K derived: sum of 2 quarters · filed 2022-03-08 | -$5.08M derived: sum of 3 quarters · filed 2022-03-08 | -$5.14M derived: sum of 4 quarters · filed 2022-03-08 |
| 2019-12-31 | $5.27M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | -$345.00K derived: sum of 2 quarters · filed 2022-03-08 | -$408.00K derived: sum of 3 quarters · filed 2022-03-08 | $2.08M 10-K · filed 2022-03-08 |
| 2019-09-30 | -$5.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$5.68M derived: sum of 2 quarters · filed 2020-11-09 | -$3.19M 10-Q · filed 2020-11-09 | -$4.69M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | -$63.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $2.42M 10-Q · filed 2020-08-07 | $923.00K derived: sum of 3 quarters · filed 2021-02-25 | $2.39M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $2.48M 10-Q · filed 2020-05-11 | $986.00K derived: sum of 2 quarters · filed 2021-02-25 | $2.46M derived: sum of 3 quarters · filed 2021-02-25 | $2.99M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | -$1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$26.00K derived: sum of 2 quarters · filed 2021-02-25 | $510.00K derived: sum of 3 quarters · filed 2021-02-25 | $1.79M 10-K · filed 2021-02-25 |
| 2018-09-30 | $1.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $2.01M derived: sum of 2 quarters · filed 2019-11-08 | $3.29M 10-Q · filed 2019-11-08 | $4.59M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | $536.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $1.81M 10-Q · filed 2019-08-07 | $3.12M derived: sum of 3 quarters · filed 2020-02-27 | $3.29M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | $1.28M 10-Q · filed 2019-05-07 | $2.58M derived: sum of 2 quarters · filed 2020-02-27 | $2.75M derived: sum of 3 quarters · filed 2020-02-27 | $2.06M derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | $1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $1.48M derived: sum of 2 quarters · filed 2020-02-27 | $785.00K derived: sum of 3 quarters · filed 2020-02-27 | $554.00K 10-K · filed 2020-02-27 |
| 2017-09-30 | $170.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | -$520.00K derived: sum of 2 quarters · filed 2018-11-06 | -$751.00K 10-Q · filed 2018-11-06 | $801.00K derived: sum of 4 quarters · filed 2019-03-18 |
| 2017-06-30 | -$690.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | -$921.00K 10-Q · filed 2018-08-08 | $631.00K derived: sum of 3 quarters · filed 2019-03-18 | -$5.43M derived: sum of 4 quarters · filed 2019-03-18 |
| 2017-03-31 | -$231.00K 10-Q · filed 2018-05-08 | $1.32M derived: sum of 2 quarters · filed 2019-03-18 | -$4.74M derived: sum of 3 quarters · filed 2019-03-18 | -$5.22M derived: sum of 4 quarters · filed 2019-03-18 |
| 2016-12-31 | $1.55M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | -$4.51M derived: sum of 2 quarters · filed 2019-03-18 | -$4.99M derived: sum of 3 quarters · filed 2019-03-18 | -$10.52M 10-K · filed 2019-03-18 |
| 2016-09-30 | -$6.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$6.54M derived: sum of 2 quarters · filed 2017-11-07 | -$12.07M 10-Q · filed 2017-11-07 | -$12.88M derived: sum of 4 quarters · filed 2018-03-08 |
| 2016-06-30 | -$479.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | -$6.01M 10-Q · filed 2017-08-08 | -$6.82M derived: sum of 3 quarters · filed 2018-03-08 | -$2.41M derived: sum of 4 quarters · filed 2018-03-08 |
| 2016-03-31 | -$5.53M 10-Q · filed 2017-05-09 | -$6.34M derived: sum of 2 quarters · filed 2018-03-08 | -$1.93M derived: sum of 3 quarters · filed 2018-03-08 | $326.00K derived: sum of 4 quarters · filed 2018-03-08 |
| 2015-12-31 | -$809.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $3.60M derived: sum of 2 quarters · filed 2018-03-08 | $5.86M derived: sum of 3 quarters · filed 2018-03-08 | $2.76M 10-K · filed 2018-03-08 |
| 2015-09-30 | $4.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $6.67M derived: sum of 2 quarters · filed 2016-11-09 | $3.57M 10-Q · filed 2016-11-09 | $8.61M derived: sum of 4 quarters · filed 2017-03-03 |
| 2015-06-30 | $2.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | -$843.00K 10-Q · filed 2016-08-09 | $4.20M derived: sum of 3 quarters · filed 2017-03-03 | $7.44M derived: sum of 4 quarters · filed 2017-03-03 |
| 2015-03-31 | -$3.10M 10-Q · filed 2016-05-09 | $1.95M derived: sum of 2 quarters · filed 2017-03-03 | $5.19M derived: sum of 3 quarters · filed 2017-03-03 | -$304.00K derived: sum of 4 quarters · filed 2017-03-03 |
| 2014-12-31 | $5.04M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03 | $8.29M derived: sum of 2 quarters · filed 2017-03-03 | $2.79M derived: sum of 3 quarters · filed 2017-03-03 | $3.39M 10-K · filed 2017-03-03 |
| 2014-09-30 | $3.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | -$2.25M derived: sum of 2 quarters · filed 2015-11-09 | -$1.65M 10-Q · filed 2015-11-09 | -$3.49M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | -$5.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | -$4.89M 10-Q · filed 2015-08-10 | -$6.73M derived: sum of 3 quarters · filed 2016-02-29 | -$5.16M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | $601.00K 10-Q · filed 2015-05-11 | -$1.24M derived: sum of 2 quarters · filed 2016-02-29 | $332.00K derived: sum of 3 quarters · filed 2016-02-29 | $1.12M derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | -$1.84M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$269.00K derived: sum of 2 quarters · filed 2016-02-29 | $521.00K derived: sum of 3 quarters · filed 2016-02-29 | -$2.41M 10-K · filed 2016-02-29 |
| 2013-09-30 | $1.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $2.36M derived: sum of 2 quarters · filed 2014-11-06 | -$572.00K 10-Q · filed 2014-11-06 | $1.68M derived: sum of 4 quarters · filed 2015-02-26 |
| 2013-06-30 | $790.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-04 | -$2.14M 10-Q · filed 2014-08-04 | $108.00K derived: sum of 3 quarters · filed 2015-02-26 | $1.21M derived: sum of 4 quarters · filed 2015-02-26 |
| 2013-03-31 | -$2.93M 10-Q · filed 2014-05-12 | -$682.00K derived: sum of 2 quarters · filed 2015-02-26 | $421.00K derived: sum of 3 quarters · filed 2015-02-26 | $192.00K derived: sum of 4 quarters · filed 2015-02-26 |
| 2012-12-31 | $2.25M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | $3.35M derived: sum of 2 quarters · filed 2015-02-26 | $3.13M derived: sum of 3 quarters · filed 2015-02-26 | $3.70M 10-K · filed 2015-02-26 |
| 2012-09-30 | $1.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $874.00K derived: sum of 2 quarters · filed 2013-11-07 | $1.45M 10-Q · filed 2013-11-07 | $1.77M derived: sum of 4 quarters · filed 2014-03-12 |
| 2012-06-30 | -$229.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | $348.00K 10-Q · filed 2013-08-07 | $665.00K derived: sum of 3 quarters · filed 2014-03-12 | -$675.00K derived: sum of 4 quarters · filed 2014-03-12 |
| 2012-03-31 | $577.00K 10-Q · filed 2013-05-09 | $894.00K derived: sum of 2 quarters · filed 2014-03-12 | -$446.00K derived: sum of 3 quarters · filed 2014-03-12 | $2.44M derived: sum of 4 quarters · filed 2014-03-12 |
| 2011-12-31 | $317.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-12 | -$1.02M derived: sum of 2 quarters · filed 2014-03-12 | $1.87M derived: sum of 3 quarters · filed 2014-03-12 | $1.22M 10-K · filed 2014-03-12 |
| 2011-09-30 | -$1.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $1.55M derived: sum of 2 quarters · filed 2012-11-09 | $905.00K 10-Q · filed 2012-11-09 | $2.21M derived: sum of 4 quarters · filed 2013-03-12 |
| 2011-06-30 | $2.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | $2.25M 10-Q · filed 2012-08-14 | $3.55M derived: sum of 3 quarters · filed 2013-03-12 | $4.15M derived: sum of 4 quarters · filed 2013-03-12 |
| 2011-03-31 | -$645.00K 10-Q · filed 2012-05-15 | $657.00K derived: sum of 2 quarters · filed 2013-03-12 | $1.26M derived: sum of 3 quarters · filed 2013-03-12 | |
| 2010-12-31 | $1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-12 | $1.91M derived: sum of 2 quarters · filed 2013-03-12 | -$209.00K 10-K · filed 2013-03-12 | |
| 2010-09-30 | $606.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | -$1.51M 10-Q · filed 2011-11-14 | ||
| 2010-06-30 | -$2.12M 10-Q · filed 2011-08-09 | |||
| 2009-12-31 | $4.00M 10-K · filed 2012-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |